GTG.AX Shariah Compliance
Screening Methodology: AAOIFI
HALAL
Last Updated: October 19, 2023
Report Source: 2023 Annual Report
Genetic Technologies Ltd. Stock Analysis GTG.AX
Genetic Technologies Ltd. engages in the provision of molecular risk assessment tests for cancer. The company is headquartered in Melbourne, Victoria and currently employs 58 full-time employees. The firm is engaged in providing genomics-based tests on health, wellness and serious disease through its EasyDNA brand. The company offers cancer predictive testing and assessment tools to help physicians to improve health outcomes for people around the world. The firm has a proprietary risk stratification platform that integrates clinical and genetic risk to deliver outcomes to physicians and individuals. The firm's segments include EasyDNA, AffinityDNA, and GeneType/Corporate. The EasyDNA segment relates to EasyDNA branded test sales and expenses. The AffinityDNA segment relates to AffinityDNA branded test sales and expenses. GeneType/Corporate: relates to geneType branded test sales and expense, includes corporate charges.
Read More Genetic Technologies Ltd (GTG.AX) Chart
Key Statistics of Genetic Technologies Ltd (GTG.AX)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
AUD0.00Volume
500.00KP/E Ratio (TTM)
-52 Week Range
Market Cap
52.08MAvg. Volume
87.31KDividend Yield
-Financial Metrics & Statements of Genetic Technologies Ltd (GTG.AX)
FAQ's for Genetic Technologies Ltd (GTG.AX)
- According to Musaffa’s Shariah screening methodology, Genetic Technologies Ltd (GTG.AX) is currently classified as HALAL as of October 2023. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.